Next Article in Journal
Multifactorial Origin of Neurodevelopmental Disorders: Approaches to Understanding Complex Etiologies
Next Article in Special Issue
Taxane-Induced Peripheral Neurotoxicity
Previous Article in Journal
Mercury, Lead, Cadmium, Arsenic, Chromium and Selenium in Feathers of Shorebirds during Migrating through Delaware Bay, New Jersey: Comparing the 1990s and 2011/2012

L-Dopa and Brain Serotonin System Dysfunction

Department of Neurosciences, University of Toledo College of Medicine, 3000 Arlington Ave, Toledo, OH 43561, USA
Author to whom correspondence should be addressed.
Academic Editor: Guido Cavaletti
Toxics 2015, 3(1), 75-88;
Received: 22 January 2015 / Revised: 16 February 2015 / Accepted: 26 February 2015 / Published: 5 March 2015
(This article belongs to the Special Issue Toxicities of Therapeutic Agents Used in Medicine)
L-dopa is used to treat the motor symptoms associated with Parkinson’s disease, a neurodegenerative movement disorder characterized by a loss of dopamine neurons. L-dopa is the precursor to dopamine and crosses the blood-brain barrier to increase dopamine neurotransmission. This review will focus on the findings that dopamine produced from L-dopa is mediated in part by serotonin neurons. Direct evidence will be provided that increases in dopamine cause oxidative stress and damage serotonin neurons. Similarly, chronic L-dopa produces deficits in serotonin neurotransmission, including decreases in both serotonin cell bodies within the dorsal raphe and serotonin neurotransmitter concentrations in several forebrain regions. Since serotonin is involved in many important physiological processes including mood and cognition, L-dopa induced serotonin deficits may play a role in the side-effect symptoms observed in Parkinson’s disease patients treated with L-dopa. View Full-Text
Keywords: 6-hydroxydopamine; dopamine; L-dopa; non-motor symptoms; Parkinson’s disease; serotonin neurons 6-hydroxydopamine; dopamine; L-dopa; non-motor symptoms; Parkinson’s disease; serotonin neurons
MDPI and ACS Style

Stansley, B.J.; Yamamoto, B.K. L-Dopa and Brain Serotonin System Dysfunction. Toxics 2015, 3, 75-88.

AMA Style

Stansley BJ, Yamamoto BK. L-Dopa and Brain Serotonin System Dysfunction. Toxics. 2015; 3(1):75-88.

Chicago/Turabian Style

Stansley, Branden J., and Bryan K. Yamamoto. 2015. "L-Dopa and Brain Serotonin System Dysfunction" Toxics 3, no. 1: 75-88.

Find Other Styles

Article Access Map by Country/Region

Only visits after 24 November 2015 are recorded.
Back to TopTop